Delivery Order SPE2DR25D6028-SPE2DR26FARWE
- Not listed
- The Defense Logistics Agency awarded a $23,688.39 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ondansetron ODT (orally disintegrating tablets) 8mg in a 30-count quantity. This is a firm fixed-price, competitively awarded contract with a completion date of December 12, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a $35,821.40 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT (orally disintegrating tablet) 4mg in a 30-count package. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 7, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,754.83 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, valued at $2,026.39, represents a competitively awarded, non-set-aside contract with performance centered at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,328.04 under firm fixed-price terms, with an ultimate completion date of July 31, 2025. The pharmaceutical products will be delivered to the contracting location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $12,595.18 to AmerisourceBergen Drug Corp for Ondansetron ODT (orally disintegrating tablet) 4mg in a 30-count supply. This is a firm fixed-price delivery order with no set-aside designation, issued on December 5, 2025, with an ultimate completion date of January 5, 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.80 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea...
- The Defense Logistics Agency awarded a delivery order valued at $4,566.42 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablet) 8 mg in quantities of 30 tablets. The contract is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and was awarded on September 18, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Ondansetron ODT (orally disintegrating tablet) 8mg in a quantity of 30 tablets, with a ceiling value of $6,070.84 and a firm fixed price structure. The delivery order, which is a child contract under a larger vehicle, has an ultimate completion date of October 20, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package. This is a firm fixed price delivery order with a ceiling value of $3,275.55 and an ultimate completion date of October 20, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARWEDelivery Order
The Defense Logistics Agency awarded a $19,097.78 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT (orally disintegrating tablet) 8mg in a 30-count quantity. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 11, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to military healthcare programs worldwide. Ondansetron is a commonly used antiemetic medication within military and federal healthcare systems, employed for nausea and vomiting management across various treatment contexts. AmerisourceBergen's extensive federal pharmaceutical distribution network, combined with its strategic position as a prime vendor for DLA's medical supply chain, positions the company to fulfill such critical medical commodity requirements efficiently. The competitive nature of this award and the company's demonstrated capability across multiple therapeutic domains reflect its established role as a major pharmaceutical distributor supporting federal military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 12/10/25 |